Veracyte, Inc. Files 8-K on Financials
Ticker: VCYT · Form: 8-K · Filed: Nov 4, 2025 · CIK: 1384101
| Field | Detail |
|---|---|
| Company | Veracyte, Inc. (VCYT) |
| Form Type | 8-K |
| Filed Date | Nov 4, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: VCYT
TL;DR
VERACYTE just dropped their 8-K. Check financials NOW.
AI Summary
Veracyte, Inc. filed an 8-K on November 4, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details the company's operational and financial status as of the reporting date.
Why It Matters
This filing provides investors and stakeholders with crucial updates on Veracyte's financial performance and operational standing, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing and does not inherently introduce new risks.
Key Players & Entities
- VERACYTE, INC. (company) — Registrant
- November 4, 2025 (date) — Date of Report
- 001-36156 (other) — Commission File Number
- 20-5455398 (other) — IRS Employer Identification No.
- 6000 Shoreline Court, Suite 300, South San Francisco, California 94080 (address) — Principal executive offices
FAQ
What is the primary purpose of this Form 8-K filing for Veracyte, Inc.?
The primary purpose is to report on Veracyte, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
On what date was this 8-K filing submitted?
The filing was submitted on November 4, 2025.
What is Veracyte, Inc.'s principal executive office address?
Veracyte, Inc.'s principal executive office is located at 6000 Shoreline Court, Suite 300, South San Francisco, California 94080.
What is Veracyte, Inc.'s Commission File Number?
Veracyte, Inc.'s Commission File Number is 001-36156.
What is Veracyte, Inc.'s IRS Employer Identification No.?
Veracyte, Inc.'s IRS Employer Identification No. is 20-5455398.
Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-11-04 16:08:20
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share VCYT The Nasdaq Stock Market
Filing Documents
- vcyt-20251104.htm (8-K) — 28KB
- vcyt-11x04x20258xkearnings.htm (EX-99.1) — 338KB
- vcytlogoa.gif (GRAPHIC) — 6KB
- 0001384101-25-000128.txt ( ) — 514KB
- vcyt-20251104.xsd (EX-101.SCH) — 2KB
- vcyt-20251104_lab.xml (EX-101.LAB) — 22KB
- vcyt-20251104_pre.xml (EX-101.PRE) — 13KB
- vcyt-20251104_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On November 4, 2025, Veracyte, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2025. The full text of the press release is furnished as Exhibit 99.1 to this report. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued by Veracyte, Inc. dated November 4 , 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 4, 2025 VERACYTE, INC. By: /s/ Rebecca Chambers Name: Rebecca Chambers Title: Chief Financial Officer Principal Financial Officer